Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sweet Green Fields is a leading global biotechnology company specializing in the research, development, and production of high-purity stevia extracts. Founded in 2007, the company focuses on creating natural, non-caloric sweetening solutions to support sugar reduction in the food and beverage industry. Their portfolio includes proprietary stevia varieties and advanced glycoside blends like the Optimizer and Intesse series. In 2020, the company was acquired by Tate & Lyle, integrating its supply chain and R&D capabilities into a global leader in ingredient solutions. Sweet Green Fields operates with a vertically integrated model, managing everything from plant breeding to final manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sweet Green Fields.